Ronald P. Kaufman
Papers
9
Total Citations
230
H-Index
7
About
Dr. Ronald P. Kaufman is a leading urologic surgeon and researcher whose work has fundamentally advanced the surgical treatment of benign prostatic hyperplasia (BPH). His primary research focus is on Aquablation therapy, a novel, robotically-assisted waterjet ablation technique for treating lower urinary tract symptoms. Dr. Kaufman’s most significant contributions come from his leadership in the landmark WATER II clinical trial, which demonstrated the long-term safety and efficacy of Aquablation for patients with large prostates (80-150 mL)—a population with historically limited, more invasive surgical options. His highly cited publications, including the 1-year and 5-year results from WATER II (with 63 and 49 citations, respectively), have established this procedure as a viable, less morbid alternative to open prostatectomy. Beyond BPH, Dr. Kaufman has also made notable contributions to robotic-assisted surgery for ureteral obstruction and to enhanced recovery pathways in nephrectomy, showing a commitment to reducing patient opioid use and hospital costs. His work has directly shaped modern urologic practice, offering patients with challenging anatomies a safer path to symptom relief.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9